Identifying a predictive biomarker for taxane in patients with metastatic Castration Resistant Prostate Cancer (mCRPC)
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to assess the association between TLE3 and TLR4 over-expression and Prostate-specific antigen (PSA) response rate in mCRPC patients treated with docetaxel.
Description
The purpose of this study is to assess the association between TLE3 and TLR4 over-expression and Prostate-specific antigen (PSA) response rate in mCRPC patients treated with docetaxel.
Details
| Condition | prostate cancer |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX7266 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.